The program is led by director Heather M. Brandt, PhD, a social and behavioral scientist and leader in cancer prevention and control, primarily in HPV vaccination and cervical cancer screening. Her research focuses on working with stakeholders to prevent and control cancer by using evidence-based interventions through innovative, partnered approaches. She is also a member of the Department of Epidemiology & Cancer Control.
“I love the mission of St. Jude Children's Research Hospital. I've worked in areas where I've seen firsthand how St. Jude will go above and beyond to accommodate the patient, the patient's parents/caregivers and family. It brings me joy to know this and how I'm able give this testimony of what a great place this is to work.”
“Through my work with the HPV Cancer Prevention Program, I hope that the general public will learn about the accessibility, safety, and efficacy of this vaccine,” says Brown. “I hope that there will be an increase in vaccination rates and a decrease in the number of deaths related to HPV cancers. There are so many tools and resources available to us that we can see prevention accomplished during our lifetime.”
“As a program coordinator, I hope to educate parents and caregivers that HPV vaccination is cancer prevention, and that the HPV vaccination protects against more than 90% of HPV cancers. In my work, I expect to provide parents and caregivers with the resources and tools, as well as work with healthcare providers to increase the recommendation so that more children will receive HPV vaccinations. With partnerships on a local, state, and national level we can achieve the Healthy People 2030 goal of getting 80% of children vaccinated against HPV.”
“A major part of my work is centered around developing partnerships to help increase the HPV vaccination rates in the communities we serve,” says Minor. “The work is done through encouraging provider recommendations to vaccinate and educating parents around the safety, efficacy and lasting effects of the HPV vaccine.”
"The HPV vaccine is one of the major breakthroughs in cancer prevention in the last two decades. Yet, public awareness of the vaccine and the fact that vaccination can start at age nine has been low. Through my work at St. Jude, I hope to educate our communities about the importance of HPV vaccination, identify and overcome barriers to increasing HPV vaccination rates, and work alongside our partners to achieve our shared objective of cancer prevention."